कृपया अन्य खोज का प्रयास करें
Kainos Medicine, Inc. researches and develops various medicines for cancers, brain, and infectious diseases in South Korea and internationally. The company’s product pipeline includes KM-819, which is completed Phase I clinical study for the treatment of Parkinson’s disease; and KM023, a novel non-nucleoside reverse transcriptase inhibitor that is in Phase III clinical study to treat HIV/AIDS. It is also developing anticancer agents, including DNA methyltransferase inhibitor; gene target anti-cancer agent; and Ara-C, a cytotoxic anti-cancer agent to treat acute myeloid leukemia, as well as small molecule immuno-oncology drugs that modulate anti-cancer abilities of immune cells. In addition, the company is involved in the discovery of a Hepatitis B drug. It has a collaboration agreement with Emmaus Life Sciences, Inc. for the preclinical development of IRAK4 inhibitor as potential anti-cancer drug. Kainos Medicine, Inc. was incorporated in 2007 and is headquartered in Seongnam-si, South Korea.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
John J. Toole | 67 | - | Member of Scientific Advisory Board |
Jong Sik Lee | - | - | Member of Scientific Advisory Board |
Carrolee Barlow | 58 | - | Member of Scientific Advisory Board |
Kim Eunhee | - | - | Member of Scientific Advisory Board |
Suh Tae Hwan | - | - | Independent Director |
M. C. Kang | - | - | Member of Scientific Advisory Board |
Victor E. Marquez | - | - | Member of Scientific Advisory Board |
Jaemoon Lee | 63 | - | Chief Business Officer, VP of Biology & Internal Director |
Stephen Frye | - | - | Member of Scientific Advisory Board |
Ki-Sub Lee | 71 | - | Chairperson, Co-Founder & CEO |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है